Cargando…
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
The COVID-19 pandemic is a global public health crisis, with considerable mortality and morbidity exerting pressure on health-care resources, including critical care. An excessive host inflammatory response in a subgroup of patients with severe COVID-19 might contribute to the development of acute r...
Autores principales: | Mehta, Puja, Porter, Joanna C, Manson, Jessica J, Isaacs, John D, Openshaw, Peter J M, McInnes, Iain B, Summers, Charlotte, Chambers, Rachel C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834476/ https://www.ncbi.nlm.nih.gov/pubmed/32559419 http://dx.doi.org/10.1016/S2213-2600(20)30267-8 |
Ejemplares similares
-
Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021) -
Leukotrienes, mast cells, and T cells
por: McInnes, Iain B
Publicado: (2003) -
Introduction
por: McInnes, Iain B
Publicado: (2003) -
Fractional Flow Reserve: From Homeland to Colony
por: Fan, Guo-Xin, et al.
Publicado: (2016) -
Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody: Long‐Term Safety and Efficacy in Patients With Rheumatoid Arthritis
por: Burmester, Gerd R., et al.
Publicado: (2018)